Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type

Stopped It was difficult to secure enrollment of the targeted number of subjects.

Conditions

• Agitation Associated With Dementia of the Alzheimer's Type

Interventions

• DRUG: 2 mg/day
• DRUG: 3 mg/day
• DRUG: 6 mg/day
• DRUG: Placebo (0 mg/day)

Sponsor

Otsuka Pharmaceutical Co., Ltd.